Actively hiring
Locks, Safes & Home Security Products
Health Care
As featured in
Follow
Overview
News
Salaries
Products
People
Growth
Offices
Financials
Funding and backers
Total raised
$20M
1 round on record
Latest round
$20M
Seed · Oct 2024 · 23 mo ago
Team
51-200
employees, estimated range
Backers
2
Innovation Endeavors, Wireframe Ventures
The money's age
Due for its next round
23 months since the last round · not hiring
Momentum
0/100
no fresh signals
Last sign of life
this month
a posting or a news item
The story so fareach stage dated by its source: the company's releases, the press, registers, filings
May 18
New executive Passkey Therapeutics Appoints Mandeep Kaur, MD, MS, as Chief Medical Officer to Advance Clinical Validation of Its Computational Genetics-Based Novel… · morningstar.com
Oct 21, 2024
Raised a round Seed $20M
Funding rounds
| Round | Date | Amount | Investors | Source |
|---|---|---|---|---|
| Seed | Oct 2024 | $20M | — | businesswire.com |
Backed byfrom the funds' portfolios and accelerator catalogs
Investors in similar startupsfunds that back the companies most like this one

backs Qeeper logo

backs First Alert
Similar startupsby what they do, their industry and backers

Need an Expert Heating Engineer, Plumber, Electrician, Handyman, Appliance Engineer or Locksmith in London? Contact Qeeper to book your…

Createrna is an innovative drug research and development company in the clinical stage.

0 On-demand guidance from an attorney to get you home safe. Latest News and Updates What is TurnSignl?

Plotlogic is an Australian mining technology company founded in 2018. Its OreSense system uses hyperspectral sensing and AI to identify ore…

MISO offers to test anticancer drug candidates in combination with FDA-approved radiotherapy. Our drug combination assay is done on a…

The world's first searchable ecosystem of linked genetic and medical data. Get paid to share your health and genetic data with researchers.
News
Passkey Therapeutics Appoints Mandeep Kaur, MD, MS, as Chief Medical Officer to Advance Clinical Validation of Its Computational Genetics-Based Novel Drug Combination Platform
CAMBRIDGE, Mass., May 19, 2026--Passkey Therapeutics, the architect of the Locksmith platform for systematically identifying new therapeutic opportunities from synergistic drug combinations, today announced the appointment of Mandeep Kaur, MD, MS, as Chie
Read more
Report
Passkey Therapeutics Appoints Mandeep Kaur, MD, MS, as Chief Medical Officer to Advance Clinical Validation of Its Computational Genetics-Based Novel Drug Combination Platform
Read more
Report
Passkey Therapeutics: $20 Million (Seed) Raised To Address Complex Diseases
Passkey Therapeutics, a pioneer of Synergistic Multifunctional Therapeutics (SMThs), announced that it has emerged from stealth with $20 million in seed funding led by Breakout Ventures along with founding investors Innovation Endeavors and Bison Ventures
Read more
Report
Offices
Where the company hires and what each office is for
Cities
1
Hiring now
0
Countries
1
Cambridge
United States
Regional office
50-200 est. staff
245 Main Street 2nd floor, Cambridge, MA, 02142, US
Financials
Total raised
$20M
Latest round
Seed
Funding rounds
1
Funding rounds
| Round | Announced | Amount | |
|---|---|---|---|
| Seed | 2024 | $20M | Details |

Innovation Endeavors
Wireframe Ventures 


